These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 26174543)

  • 1. Breaking down silos for improved biomarker development: an interview with George Poste.
    Poste G; Raison C
    Expert Rev Mol Diagn; 2015; 15(8):975-8. PubMed ID: 26174543
    [No Abstract]   [Full Text] [Related]  

  • 2. A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.
    Raj DA; Fiume I; Capasso G; Pocsfalvi G
    Kidney Int; 2012 Jun; 81(12):1263-72. PubMed ID: 22418980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer biomarker profiles in urinary sediments and exosomes.
    Dijkstra S; Birker IL; Smit FP; Leyten GH; de Reijke TM; van Oort IM; Mulders PF; Jannink SA; Schalken JA
    J Urol; 2014 Apr; 191(4):1132-8. PubMed ID: 24211598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary exosomes and proteomics.
    Moon PG; You S; Lee JE; Hwang D; Baek MC
    Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes: proteomic insights and diagnostic potential.
    Simpson RJ; Lim JW; Moritz RL; Mathivanan S
    Expert Rev Proteomics; 2009 Jun; 6(3):267-83. PubMed ID: 19489699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes as biomarker treasure chests for prostate cancer.
    Duijvesz D; Luider T; Bangma CH; Jenster G
    Eur Urol; 2011 May; 59(5):823-31. PubMed ID: 21196075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing Biomarkers for MS.
    Gnanapavan S; Giovannoni G
    Curr Top Behav Neurosci; 2015; 26():179-94. PubMed ID: 25502545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical considerations when analyzing biomarker data.
    Beam CA
    Clin Immunol; 2015 Nov; 161(1):31-6. PubMed ID: 26111480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion.
    Jeter CB; Hergenroeder GW; Hylin MJ; Redell JB; Moore AN; Dash PK
    J Neurotrauma; 2013 Apr; 30(8):657-70. PubMed ID: 23062081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides.
    Clerico A; Passino C; Franzini M; Emdin M
    Clin Chim Acta; 2015 Mar; 443():17-24. PubMed ID: 24937843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking down IT silos: a "connected" way to improve customer experience and the bottom line.
    Hallowell B; Turisco F
    Healthc Financ Manage; 2009 Mar; 63(3):58-62, 64. PubMed ID: 20669844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking down silos and building teamwork.
    Lunn T
    Hosp Mater Manage Q; 1997 Nov; 19(2):9-15. PubMed ID: 10174000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CE-MS-based proteomics in biomarker discovery and clinical application.
    Pontillo C; Filip S; Borràs DM; Mullen W; Vlahou A; Mischak H
    Proteomics Clin Appl; 2015 Apr; 9(3-4):322-34. PubMed ID: 25641774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes: the future of biomarkers in medicine.
    Properzi F; Logozzi M; Fais S
    Biomark Med; 2013 Oct; 7(5):769-78. PubMed ID: 24044569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome.
    Rood IM; Deegens JK; Merchant ML; Tamboer WP; Wilkey DW; Wetzels JF; Klein JB
    Kidney Int; 2010 Oct; 78(8):810-6. PubMed ID: 20686450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA in melanoma-derived exosomes.
    Gajos-Michniewicz A; Duechler M; Czyz M
    Cancer Lett; 2014 May; 347(1):29-37. PubMed ID: 24513178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors.
    Lässer C
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S189-97. PubMed ID: 22506888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary exosomes and diabetic nephropathy: a proteomic approach.
    Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C; Rani S; O'Driscoll L
    Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.